Markets
BSE See NSE See 39,132.83
86.49 (0.22%)
collapse Related Readings collapse

Divi's Laboratories: Recommendation Review

| 6/14/2012 9:00 PM Thursday

We had recommended Divi’s Laboratories in DSIJ Issue No. 11 (Dated May 7-20, 2012), when the scrip was trading at Rs 864. We had recommended the scrip as being among those that could help you protect your portfolio from inflationary pressures.

The pharmaceuticals sector has been a safe haven for investors to park their funds during turbulent times. Moreover, our recommendation was also backed by other factors including the company's meticulous product selection, a pipeline of more than 20 products and the forthcoming patent expiries, because of which it is set to witness better growth in the coming years.

On the financial front, the performance for FY12 has been quite good. The topline witnessed growth of 41 per cent on a YoY basis, and stood at Rs 1858.59 crore. This strong performance was aided by a ramp-up in its new capacity at Vizag and favourable currency movement. The management has surpassed its 25 per cent topline growth guidance for FY12, and expects a 25 per cent growth in FY13 and FY14 too. On the valuations front, the stock discounts its trailing 12-month earnings by 23.52x and the EV/EBITDA stands at 20x. At the current market price, we suggest booking partial profits to the extent of at least 50 per cent of one’s holdings.

 

Find More Articles on: DSIJ Magazine, Reviews, Stock Recommendations, Fundamental Picks, Product, Large Cap

news letter

More for the early bird.

Get the post-market reports and breakfast news right in your inbox. See latest »

DSIJ Mindshare

Markets may open with a gap-up riding on global optimism

Karan DSIJ / Article rating: 5.0

The outlook for the Indian markets is a gap-up opening on the back of optimism in the global markets. The US and China will restart trade negotiations to reach a deal, Also, the ECB President surprised the markets by hinting at more stimulus if needed. At the time of writing, the SGX Nifty was trading higher by 50 points at 11,762.

12345678910Last

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Tiger Logistics topline to grow by 10%--buoyant over infra sector status to logistics sector

Logistics sector will play a vital role in making the concept of ‘Make in India’ a success. This will be further aided by some of the recent steps taken by Government of India such as granting of infra sector status to logistics sector.

Best and worst Performing Sector Funds of Year 2017

Best and worst Performing Sector Funds of Year 2017

As the year-end has approached most of you are eager to know the mutual fund movers and shakers of the year 2017. Read on to find the performance of various sector dedicated funds.

Markets may start positive, but volatility likely due to F&O expiry

Markets may start positive, but volatility likely due to F&O expiry

The start of the F&O expiry day is likely to be in the green, but volatility may creep in with the progress of the session. The SGX Nifty suggests that the Nifty could open at 10,525 with gains of 32 points at the opening bell. 

Pidilite announces buyback of Rs 500 crore

Pidilite announces buyback of Rs 500 crore

The buyback offer comprises purchase of up to 50,00,000 equity shares. The buyback offer size comprises 0.975 per cent of the total paid-up equity capital of the company.

Bank Nifty drags markets to close in the red

Bank Nifty drags markets to close in the red

The late session fall in Bank Nifty changed the direction of the market, leading to a marginal fall in the benchmark indices. Bank Nifty yet again resisted at its multiple point downward sloping trendline level at 25733.

Six major underperforming MF schemes having higher expense ratios

Six major underperforming MF schemes having higher expense ratios

Mutual funds with a large size of assets under management (AUMs) are supposed to have lower expense ratios. However, there are schemes with large AUMs but having higher expense ratios and generating lower returns. 

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma supports market; Sun Pharma at bullish reversal

Nifty Pharma index has come in as the healer in an otherwise sluggish market. Index has given a consolidation breakout at the 9420 level today and if the it sustains 9420, followed by 9628 on the upside, it has a long way to go.

Ten stocks close to their 52-week low

Ten stocks close to their 52-week low

Following stocks are close to their 52-week low as at 12.35 p.m. on December 27.

Ten stocks close to their 52-week high

Ten stocks close to their 52-week high

The markets on December 27 opened gap down. BSE Sensex is trading at 34,068.15, up by 57.54 points and the Nifty is trading at 10,539.45, up by 7.95 points.

Five stocks with selling interest

Five stocks with selling interest

Overall volumes in futures & options currently stand at 62.75 lakh contracts with a turnover of Rs. 5,19,204.72 crore.